| Author |
Title |
Year |
Publication |
Volume |
Pages |
| Brown, D.V.; Filiz, G.; Daniel, P.M.; Hollande, F.; Dworkin, S.; Amiridis, S.; Kountouri, N.; Ng, W.; Morokoff, A.P.; Mantamadiotis, T. |
Expression of CD133 and CD44 in glioblastoma stem cells correlates with cell proliferation, phenotype stability and intra-tumor heterogeneity |
2017 |
PloS one |
12 |
e0172791 |
| Ludwig, K.; Kornblum, H.I. |
Molecular markers in glioma |
2017 |
Journal of Neuro-Oncology |
|
|
| Alshehri, M.M.; Robbins, S.M.; Senger, D.L. |
The Role of Neurotrophin Signaling in Gliomagenesis: A Focus on the p75 Neurotrophin Receptor (p75NTR/CD271) |
2017 |
Vitamins and Hormones |
104 |
367-404 |
| D'Alessandris, Q.G.; Biffoni, M.; Martini, M.; Runci, D.; Buccarelli, M.; Cenci, T.; Signore, M.; Stancato, L.; Olivi, A.; De Maria, R.; Larocca, L.M.; Ricci-Vitiani, L.; Pallini, R. |
The clinical value of patient-derived glioblastoma tumorspheres in predicting treatment response |
2017 |
Neuro-Oncology |
19 |
1097-1108 |
| Howard, C.M.; Valluri, J.; Alberico, A.; Julien, T.; Mazagri, R.; Marsh, R.; Alastair, H.; Cortese, A.; Griswold, M.; Wang, W.; Denning, K.; Brown, L.; Claudio, P.P. |
Analysis of Chemopredictive Assay for Targeting Cancer Stem Cells in Glioblastoma Patients |
2017 |
Translational Oncology |
10 |
241-254 |
